CClinicalTrials.gg
CompletedNCT07014033SUMU-EndoUpdated May 15, 2026Results posted

Single-use Versus Multiple-use Endoscopes in Gastroenterology

An observational study in Endoscopy, Gastrointestinal, sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by University Hospitals Coventry and Warwickshire NHS Trust · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
39
Ages
18 Years and older
Sex
All
01

Study summary

Gastroenterology is a branch of medicine that looks after people with problems in the gut (including the stomach and bowels) using an endoscope. An endoscope is a thin tube with a light and camera at the end, which is used to look inside bits of the body, for example the stomach, bile ducts (tubes that connect the liver and gallbladder to the bowel) or large bowel. Some have extra bits attached to take samples of tissue to look at under a microscope. These tubes are made mostly of plastic.

Around 1.5 million endoscopies are performed each year in the UK. In the NHS, most endoscopes are re-usable and are used hundreds of times after cleaning and disinfection. They must be very carefully cleaned and disinfected to reduce the risk of passing on infections to other patients as well as the healthcare staff who use the equipment. If endoscopes are cleaned and disinfected properly, the risk of infection will be very low. However there have been reports of infections, which may be related to disinfection not being done properly. Disposable single-use endoscopes are now available, designed to reduce the risk of infection. These are thought to be just as good as re-usable endoscopes. However, if we switch to disposable endoscopes, it may increase the cost to the NHS. There will also be an effect on the environment from using limited resources to make endoscopes, and get rid of them by incineration (burning) or burial in landfill waste.

The aim of this research is to provide evidence on the arguments for and against the use of single-use vs. multiple-use endoscopes in gastroenterology for NHS decision makers, especially regarding cost-effectiveness and effect on the environment. This will help the aim of the NHS in England to be "the world's first 'net zero' national health service.

02

Conditions studied

  • Endoscopy, Gastrointestinal
03

In context

Lead sponsor

University Hospitals Coventry and Warwickshire NHS Trust is the lead sponsor of 54 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have attended or are scheduled to attend the endoscopy clinic at selected hospital sites.

Staff who work in the endoscopy pathway: doctors/nurses, decontamination technicians etc.

Inclusion criteria

Patients

  • Over the age of 18
  • Patient has been invited to an NHS endoscopic clinic to undertake an upper GI endoscope procedure, including diagnostic endoscopies and the less complex therapeutic endoscopy.
  • Patient is able to read and understand information provided
  • Patient has capacity to provide consent
  • Patient is able to participate in an interview. Staff
  • Over the age of 18
  • Employed by the NHS
  • Working in relevant endoscopy unit - primary work involves the conduct of endoscopy and/or waste disposal services (decontamination or disposal).

Exclusion criteria

Exclusion Criteria:

  • Patient has received a lower GI endoscopy, e.g. colonoscopy or sigmoidoscopy
  • Non-NHS service providers and receivers. (e.g., private diagnostic clinics)
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
39 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients

    Patients who have recieved an Upper GI endoscopy

  • Staff

    Staff working in the endoscopy pathway

06

What researchers measure

Primary outcomes

  1. Qualitative Interview Study

    Number of participants recruited to interview

    Time frame: 8 months

07

Results

Posted May 15, 2026
Limitations and caveats
No sites using single-use endoscopes were included, despite attempts to recruit them.

Participant flow

Participant flow — Overall Study
MilestonePatientsStaff
Started1821
Completed1821
Not completed00

Outcome measures

PrimaryQualitative Interview Study

Number of participants recruited to interview

Time frame:
8 months
Reported as:
Count of participants · Participants
Qualitative Interview Study
ParticipantsPatientsStaff
Qualitative Interview Study1821

Adverse events

Collected over No adverse events collected as this is a qualitative study. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Patients———
Staff———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)PatientsStaffTotal
<=18 years000
Between 18 and 65 years102030
>=65 years819
Sex: Female, Male
Sex: Female, Male(Participants)PatientsStaffTotal
Female81321
Male10818
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)PatientsStaffTotal
White181533
Asian or Asian British044
Black011
Any other ethnic background011
08

Study locations

1 site
  • University Hospital Coventry and Warwickshire NHS Trust
    Coventry, CV2 2DX, United Kingdom
09

References and documents

Study documents

  • Study protocol · Jun 24, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07014033
Lead sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Responsible party
Sponsor
First posted
Jun 10, 2025
Start date
Oct 16, 2024
Primary completion
Jun 30, 2025
Completion
Dec 31, 2025
Results posted
May 15, 2026
Last update
May 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion